CheckEye

CheckEye — Innovative HealthTech Startup in Preventive Medicine

CheckEye has developed an AI-powered platform for mass screening of chronic diseases linked to vascular changes. Our solution is already operational for detecting early signs of diabetic retinopathy and, by 2026, will expand to cover hypertension, glaucoma, age-related macular degeneration, and 50+ other conditions.

Our experience & expertise:

• 20+ years of digital transformation expertise from our founder.

• 20+ years of medical expertise in ophthalmology and retina care.

• Partnerships with leading medical institutions, including the Filatov Institute of Eye Diseases and Tissue Therapy and the Ukrainian Diabetic Federation.

Key achievements:

• Winner of EIT Health InnoStars 2024.

• 10,000+ screenings already conducted in collaboration with hospitals, pharmacies, and patient associations.

• Pilots launched in Austria, Germany, Oman, Malaysia, and Romania.

• Featured at global medical events: World Diabetes Congress, EURetina Innovation Spotlight, CES.

What makes us unique:

• Scalable screening — from hospitals to mobile units.

• Results in under 60 seconds, without specialist involvement.

• Proven accuracy: 95% sensitivity, 93% specificity.

• Designed for regions with overstretched healthcare systems or limited access to doctors.

Our mission is clear: to make preventive medicine accessible to everyone and add healthy years to people’s lives worldwide.